Kari Alitalo

Kari Kustaa Alitalo (born 21 May 1952 Kuopio [1]) is a Finnish MD and a medical researcher. He is a foreign associated member of the National Academy of Sciences of the USA.[2] He became famous for his discoveries of several receptor tyrosine kinases (RTKs)[3][4][5] and the first growth factor capable to induce lymphangiogenesis: vascular endothelial growth factor C (VEGF-C).[6] In the years 1996–2007 he was Europe's second most cited author in the field of cell biology.[7] Alitalo is currently serving as an Academy Professor for the Academy of Finland.[8]

Alitalo received the Leopold Griffuel Prize in 2002[9] and the 2006 Louis-Jeantet Prize for Medicine.[10] He also received the 2005 Eric Fernström Foundation's Nordic Prize[11] and the 2009 In-Bev Baillet Latour Health Prize.[12] In 2014, he received the Dr. A.H.Heineken Prize for Medicine.

References

  1. ↑ Pajala, Lasse (2010). Kuka kukin on 2011 (in Finnish). Otava. ISBN 978-951-1-24712-8.
  2. ↑ National Academy of Sciences Members and Foreign Associates Elected News, April 30th, 2013, National Academy of Sciences. Accessed June 3, 2013
  3. ↑ Partanen, J; Mäkelä, TP; Eerola, E; Korhonen, J; Hirvonen, H; Claesson-Welsh, L; Alitalo, K (1991). "FGFR-4, a novel acidic fibroblast growth factor receptor with a distinct expression pattern". The EMBO Journal. 10 (6): 1347–54. PMC 452793Freely accessible. PMID 1709094.
  4. ↑ Aprelikova, O; Pajusola, K; Partanen, J; Armstrong, E; Alitalo, R; Bailey, SK; McMahon, J; Wasmuth, J; et al. (1992). "FLT4, a novel class III receptor tyrosine kinase in chromosome 5q33-qter". Cancer Research. 52 (3): 746–8. PMID 1310071.
  5. ↑ Partanen, J; Armstrong, E; Mäkelä, TP; Korhonen, J; Sandberg, M; Renkonen, R; Knuutila, S; Huebner, K; Alitalo, K (1992). "A novel endothelial cell surface receptor tyrosine kinase with extracellular epidermal growth factor homology domains". Molecular and Cellular Biology. 12 (4): 1698–707. PMC 369613Freely accessible. PMID 1312667.
  6. ↑ Joukov, V; Pajusola, K; Kaipainen, A; Chilov, D; Lahtinen, I; Kukk, E; Saksela, O; Kalkkinen, N; Alitalo, K (1996). "A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases". The EMBO Journal. 15 (2): 290–98. PMC 449944Freely accessible. PMID 8617204.
  7. ↑ "Publication Analysis 1996-2007. Cell Biology." Lab Times. 2007. Number 5, pages 42-44
  8. ↑ "Akatemiaprofessorit". Academy of Finland. 27 May 2015. Retrieved 28 May 2015.
  9. ↑ Leopold Griffuel Prize. Wikipedia. Accessed June 3rd, 2013
  10. ↑ Professor Kari Alitalo. Winner of the 2006 Louis-Jeantet Prize for medicine. Louis-Jeantet Foundation. Accessed August 21, 2011
  11. ↑ Kari Alitalo received recognition for his work, University of Helsinki 2005 annual report. Accessed August 21, 2011
  12. ↑ FINISH PROFESSORS KARI ALITALO AND SEPPO YLÄ-HERTTUALA ARE RECIPIENTS OF THE INBEV-BAILLET LATOUR HEALTH PRIZE 2009 FOR THEIR PIONEERING RESEARCH ON CARDIOVASCULAR DISORDERS. Press-release, April 2009, In-Bev Baillet Latour Foundation. Accessed August 21, 2011

External links

This article is issued from Wikipedia - version of the 10/7/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.